Skip to content

Clinical trials

Glomerulosclerosis, Focal Segmental trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulosclerosis, Focal Segmental Country / region: France Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20183
20201
20223
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting5
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris2
Amgen1
Boehringer Ingelheim1
Dimerix Bioscience Pty Ltd1
Nantes University Hospital1
Pfizer1
River 3 Renal Corp.1
Sanofi1
Travere Therapeutics, Inc.1
University Hospital, Limoges1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulosclerosis, Focal Segmental12
Nephrosis, Lipoid5
Kidney Diseases3
Nephrotic Syndrome2
AIDS-Associated Nephropathy1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Diabetic Nephropathies1
Glomerulonephritis, IGA1
Glomerulonephritis, Membranous1
Nephritis, Hereditary1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.